Xenon Pharmaceuticals XENE Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's book value per share?
- Xenon Pharmaceuticals (XENE) reported book value per share of $15.32 in Q1 2026.
- How has Xenon Pharmaceuticals's book value per share changed year-over-year?
- Xenon Pharmaceuticals's book value per share increased by 71.2% year-over-year, from $8.95 to $15.32.
- What is the long-term trend for Xenon Pharmaceuticals's book value per share?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's book value per share has grown at a 8.2% compound annual growth rate (CAGR), from $4.96 to $7.34.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.